SG Americas Securities »

Compass Therapeutics shares owned by SG Americas Securities

Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by SG Americas Securities from 13F filings

Historical chart of SG Americas Securities investment in Compass Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Compass Therapeutics held by SG Americas Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Therapeutics by SG Americas Securities

Quarter filed Position value Share count Share price at filing
2023-12-31 $74k 48k 1.55
2023-09-30 $76k 39k 1.96

More positions owned by SG Americas Securities

Amazon (AMZN)
iShares MSCI EAFE Index Fund (EFA)
SPDR Gold Trust (GLD)
Cisco Systems (CSCO)
Invesco Qqq Tr Opt Call Option
Apple (AAPL)
iShares MSCI Emerging Markets Indx (EEM)
Meta Platforms Opt Call Option
Spdr S&p 500 Etf (SPY)
iShares Russell 2000 Index (IWM)
Abbvie (ABBV)
Amazon Opt Call Option
Broadcom (AVGO)
Amgen (AMGN)
Caterpillar (CAT)

View all positions for SG Americas Securities

Top funds holding Compass Therapeutics

OrbiMed Advisors
Henderson Group
Blackstone Group
Vanguard Group
Vivo Capital
Blue Owl Capital Holdings
Avidity Partners Management
Baker Bros. Advisors
Monashee Investment Management
Millennium Management
Braidwell
Element Capital Management
Bank of New York Mellon
Charles Schwab Investment Management
Connor, Clark & Lunn Investment Management

View all funds holding Compass Therapeutics